Mohammed Said, MD
Urology · Louisville, KYNPI 1043601875
Payments from drug & device makers
What this record shows
This record is dominated by education: $7,504 of the $11,017 with a category attached, or 68.1%. Intuitive Surgical accounts for 75.2% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $8,950, more than ten times the $57 reported in 2020.
Across 80 payments — averaging $137.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$8K
- Boston Scientific$2K
- Coloplast$171
- KARL Storz Endoscopy-america$103
- Merck$102
- Progenics Pharmaceuticals, Inc.$93
- plus $569 from 19 others
What the payments were for
- Travel & lodging$3383%
- Food & beverage$3,17529%
- Education$7,50468%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 19 | $8,287 |
| Boston Scientific | 20 | $1,692 |
| Coloplast | 6 | $171 |
| KARL Storz Endoscopy-america | 2 | $103 |
| Merck | 5 | $102 |
| Progenics Pharmaceuticals, Inc. | 5 | $93 |
| Dendreon Pharmaceuticals LLC | 2 | $63 |
| Cook Medical LLC | 1 | $57 |
| Conmed Corporation | 1 | $56 |
| Olympus America Inc. | 2 | $53 |
| Urogen Pharma, Inc. | 2 | $44 |
| Angiodynamics, Inc. | 2 | $29 |
| Endo USA, Inc. | 1 | $28 |
| Dentsply IH Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $25 |
| Calyxo, Inc. | 1 | $24 |
| Rochester Medical Corporation | 1 | $24 |
| Verity Pharmaceuticals Inc. | 1 | $22 |
| Urovant Sciences Inc | 1 | $22 |
| Myriad Genetic Laboratories, Inc. | 1 | $21 |
| Sun Pharmaceutical Industries Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $18 |
| Pfizer | 1 | $15 |
| Civco Medical Instruments | 1 | $14 |
| Travere Therapeutics, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DA VINCI SP$7,500
- Da Vinci Surgical System$532
- LithoVue$276
- GENERAL - THERAPIES$269
- REZUM$235
- GENERAL ONCOLOGY$123
- LITHOCLAST$109
- GENERAL KIDNEY STONE DISEASE$102
How this compares
$11,017 in reported general payments places this provider in the 85th percentile of 139 urology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Finasteride | 138 | $1,473 |
| Tamsulosin Hcl | 98 | $947 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $31 |
| Oxycodone Hcl | 14 | $18 |
Paid to pharmacies, not to this prescriber.
Other urology in Louisville
- Uzoma AneleLouisville$60K
- Kellen ChoiLouisville$17K
- Rosa ParkLouisville$16K
- Terrance BlackfordLouisville$10K
- Jessica SchardeinLouisville$9K
- Jonathan WittenLouisville$9K
- Morris JacksonLouisville$7K
- Thomas SlabaughLexington$102K
- Lee EvansHopkinsville$56K
- Patrick HensleyLexington$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.